Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Hemant Surgical
Quarter-by-quarter operating performance
Financials of Hemant Surgical
Annual income statement trend
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 51 | 56 | 56 | 60 | 101 | 109 | 106 | 107 | 231 |
| Expenses + | 48 | 53 | 53 | 57 | 95 | 98 | 95 | 97 | 208 |
| Operating Profit | 2 | 3 | 3 | 3 | 6 | 11 | 10 | 9 | 23 |
| OPM % | 5% | 5% | 5% | 5% | 6% | 10% | 10% | 9% | 10% |
| Other Income + | 0 | 0 | 0 | 1 | 2 | 2 | 4 | 5 | 6 |
| Interest | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 4 |
| Depreciation | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 1 | 1 | 1 | 1 | 6 | 10 | 13 | 11 | 24 |
| Tax % | 10% | 8% | 41% | 9% | 25% | 24% | 23% | 23% | 23% |
| Net Profit + | 1 | 1 | 0 | 1 | 5 | 8 | 10 | 8 | 18 |
| EPS in Rs | 50.76 | 61.02 | 27.00 | 73.43 | 248.92 | 9.95 | 9.39 | 7.79 | 13.98 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Hemant Surgical
Capital structure and asset base
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 8 | 10 | 10 | 13 |
| Reserves | 5 | 6 | 5 | 8 | 11 | 16 | 44 | 53 | 124 |
| Borrowings + | 9 | 11 | 14 | 14 | 10 | 7 | 7 | 31 | 50 |
| Other Liabilities + | 12 | 14 | 23 | 15 | 32 | 34 | 38 | 54 | 87 |
| Total Liabilities | 28 | 33 | 44 | 40 | 54 | 65 | 100 | 148 | 274 |
| Fixed Assets + | 7 | 8 | 10 | 11 | 12 | 13 | 18 | 40 | 53 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 0 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 5 | 1 | 0 |
| Other Assets + | 21 | 25 | 33 | 29 | 42 | 51 | 77 | 94 | 220 |
| Total Assets | 28 | 33 | 44 | 40 | 54 | 65 | 100 | 148 | 274 |
Financials of Hemant Surgical
Operating, investing and financing cash movement
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 0 | 0 | 2 | -4 | 12 | 6 | -4 | 9 | -32 |
| Cash from Investing Activity + | 0 | 0 | -2 | -2 | -0 | -3 | -12 | -30 | -3 |
| Cash from Financing Activity + | 0 | 0 | 2 | 5 | -8 | -1 | 21 | 18 | 69 |
| Net Cash Flow | 0 | 0 | 2 | -2 | 4 | 3 | 5 | -4 | 34 |
| Free Cash Flow | 0 | 0 | -1 | -7 | 12 | 2 | -13 | -25 | -34 |
| CFO/OP | 0% | 0% | 68% | -127% | 197% | 84% | -9% | 126% | -118% |
Financials of Hemant Surgical
Working capital efficiency and return ratios
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 35 | 36 | 35 | 26 | 56 | 58 | 75 | 70 | 106 |
| Inventory Days | 64 | 73 | 125 | 113 | 57 | 67 | 99 | 205 | 120 |
| Days Payable | 102 | 97 | 143 | 89 | 92 | 110 | 116 | 188 | 146 |
| Cash Conversion Cycle | -3 | 12 | 17 | 51 | 21 | 15 | 58 | 87 | 80 |
| Working Capital Days | 12 | 23 | -28 | 41 | -19 | 2 | 52 | 61 | 24 |
| ROCE % | 15% | 12% | 14% | 32% | 45% | 30% | 16% | 20% |
Capacity utilization currently at ~58% for test kits and ~42% for devices; automation capex will double revenue capacity with minimal new investment. Key…
Contract renewals historically exhibit a 60-70% roll-over rate annually, ensuring revenue visibility from existing clients. Key concall takeaways from QMS…
PAT grew 23.8% y-o-y in Q1 FY27, showing healthy bottom-line growth (Page 4). Key concall takeaways from Laxmi Dental Ltd's Q1 FY27 earnings call — and how it…
Plastic labware market is expanding faster than glass, currently at INR1,200 crores, signaling long-term sector growth opportunities. Key concall takeaways…